Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf Licenses Thermal Gradient IP to Analytik Jena

Premium

This article was originally published on Jan. 3.

Eppendorf said today that it has licensed patents covering its thermal cycler gradient technology to Analytik Jena, which will use the technology in its thermal cyclers.

Specifically, Eppendorf has licensed to Analytik Jena IP including US Patent Nos. 6,767,512, entitled "Temperature-regulating block with temperature-regulating devices;" and 7,074,367, entitled "Thermostated block with heat-regulating devices."

In the last year, Hamburg, Germany-based Eppendorf has licensed the '512 and '367 patents to a number of life science companies, including Takara Bio (PCR Insider, 11/17/2011), Bulldog Bio (PCR Insider, 9/8/2011), Roche, and Labnet (PCR Insider, 4/7/2011). Eppendorf also uses the technology in its own Mastercycler Pro Gradient, Mastercycler Gradient, and Mastercycler EP Realplex models.

Analytik Jena currently sells two thermal cyclers for endpoint PCR: the FlexCycler for standard PCR and the AlphaSC for rapid PCR; as well as a new platform for real-time PCR, the qTower 2.0.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.